ID

21052

Beschreibung

Hyzaar Asia HEAALTH (0954A-950); ODM derived from: https://clinicaltrials.gov/show/NCT00354991

Link

https://clinicaltrials.gov/show/NCT00354991

Stichworte

Versionen (1)
  1. 06.04.17 06.04.17 -
Hochgeladen am

6. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT00354991

Englisch

Eligibility Hypertension NCT00354991

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient is male or female and = 18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
patients with essential hypertension previously treated with antihypertensive medications for at least 4 weeks but did not reach the blood pressure goal
Beschreibung

Essential Hypertension | Antihypertensive Agents | Blood Pressure goal failed

Datentyp

boolean

Alias
UMLS CUI [1]
C0085580
UMLS CUI [2]
C0003364
UMLS CUI [3,1]
C0005823
UMLS CUI [3,2]
C0018017
UMLS CUI [3,3]
C0231175
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of any condition, therapy, lab abnormality or other circumstance that might confound the results of the study, or interfere with the patient's participation for the full duration of the study, such that it is not in the best interest of the patient/subject to participate
Beschreibung

Condition Interferes with Research results | Therapeutic procedure Interferes with Research results | Laboratory test abnormality Interferes with Research results | Circumstance Interferes with Research results | Condition Interferes with Study Subject Participation Status | Therapeutic procedure Interferes with Study Subject Participation Status | Laboratory test abnormality Interferes with Study Subject Participation Status | Circumstance Interferes with Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0683954
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0683954
UMLS CUI [3,1]
C0438215
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0683954
UMLS CUI [4,1]
C0680082
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0683954
UMLS CUI [5,1]
C0348080
UMLS CUI [5,2]
C0521102
UMLS CUI [5,3]
C2348568
UMLS CUI [6,1]
C0087111
UMLS CUI [6,2]
C0521102
UMLS CUI [6,3]
C2348568
UMLS CUI [7,1]
C0438215
UMLS CUI [7,2]
C0521102
UMLS CUI [7,3]
C2348568
UMLS CUI [8,1]
C0680082
UMLS CUI [8,2]
C0521102
UMLS CUI [8,3]
C2348568
pregnant or breastfeeding, or expecting to conceive within the projected duration of the study
Beschreibung

Pregnancy | Breast Feeding | Pregnancy Expected

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0032961
UMLS CUI [3,2]
C1517001
previous history of severe essential hypertension
Beschreibung

Essential Hypertension Severe

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085580
UMLS CUI [1,2]
C0205082
history of stroke or myocardial infarction (heart attack)
Beschreibung

Cerebrovascular accident | Myocardial Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0027051
evidence of renal or liver disease
Beschreibung

Kidney Disease Evidence of | Liver disease Evidence of

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0332120
uncontrolled diabetes mellitus
Beschreibung

Diabetic - poor control

Datentyp

boolean

Alias
UMLS CUI [1]
C0421258
any known bleeding disorder
Beschreibung

Blood Coagulation Disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C0005779
known sensitivity or intolerance to the study medication (losartan or hydrochlorothiazide)
Beschreibung

Hypersensitivity Investigational New Drugs | intolerance to Investigational New Drugs | Losartan allergy | intolerance to Losartan | Hydrochlorothiazide allergy | intolerance to Hydrochlorothiazide

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0013230
UMLS CUI [3]
C0571952
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0126174
UMLS CUI [5]
C0571898
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C0020261
other antihypertensive medications or medications that may affect blood pressure
Beschreibung

Antihypertensive Agents | Pharmaceutical Preparations Affecting Blood Pressure

Datentyp

boolean

Alias
UMLS CUI [1]
C0003364
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0005823
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hypertension NCT00354991

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patient is male or female and = 18 years of age
boolean
C0001779 (UMLS CUI [1])
Essential Hypertension | Antihypertensive Agents | Blood Pressure goal failed
Item
patients with essential hypertension previously treated with antihypertensive medications for at least 4 weeks but did not reach the blood pressure goal
boolean
C0085580 (UMLS CUI [1])
C0003364 (UMLS CUI [2])
C0005823 (UMLS CUI [3,1])
C0018017 (UMLS CUI [3,2])
C0231175 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Condition Interferes with Research results | Therapeutic procedure Interferes with Research results | Laboratory test abnormality Interferes with Research results | Circumstance Interferes with Research results | Condition Interferes with Study Subject Participation Status | Therapeutic procedure Interferes with Study Subject Participation Status | Laboratory test abnormality Interferes with Study Subject Participation Status | Circumstance Interferes with Study Subject Participation Status
Item
history of any condition, therapy, lab abnormality or other circumstance that might confound the results of the study, or interfere with the patient's participation for the full duration of the study, such that it is not in the best interest of the patient/subject to participate
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0683954 (UMLS CUI [2,3])
C0438215 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C0680082 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
C0348080 (UMLS CUI [5,1])
C0521102 (UMLS CUI [5,2])
C2348568 (UMLS CUI [5,3])
C0087111 (UMLS CUI [6,1])
C0521102 (UMLS CUI [6,2])
C2348568 (UMLS CUI [6,3])
C0438215 (UMLS CUI [7,1])
C0521102 (UMLS CUI [7,2])
C2348568 (UMLS CUI [7,3])
C0680082 (UMLS CUI [8,1])
C0521102 (UMLS CUI [8,2])
C2348568 (UMLS CUI [8,3])
Pregnancy | Breast Feeding | Pregnancy Expected
Item
pregnant or breastfeeding, or expecting to conceive within the projected duration of the study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1517001 (UMLS CUI [3,2])
Essential Hypertension Severe
Item
previous history of severe essential hypertension
boolean
C0085580 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Cerebrovascular accident | Myocardial Infarction
Item
history of stroke or myocardial infarction (heart attack)
boolean
C0038454 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Kidney Disease Evidence of | Liver disease Evidence of
Item
evidence of renal or liver disease
boolean
C0022658 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
Diabetic - poor control
Item
uncontrolled diabetes mellitus
boolean
C0421258 (UMLS CUI [1])
Blood Coagulation Disorder
Item
any known bleeding disorder
boolean
C0005779 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | intolerance to Investigational New Drugs | Losartan allergy | intolerance to Losartan | Hydrochlorothiazide allergy | intolerance to Hydrochlorothiazide
Item
known sensitivity or intolerance to the study medication (losartan or hydrochlorothiazide)
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0571952 (UMLS CUI [3])
C1744706 (UMLS CUI [4,1])
C0126174 (UMLS CUI [4,2])
C0571898 (UMLS CUI [5])
C1744706 (UMLS CUI [6,1])
C0020261 (UMLS CUI [6,2])
Antihypertensive Agents | Pharmaceutical Preparations Affecting Blood Pressure
Item
other antihypertensive medications or medications that may affect blood pressure
boolean
C0003364 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0005823 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video